These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23657267)

  • 21. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
    Sim JJ; Bhandari SK; Shi J; Reynolds K; Calhoun DA; Kalantar-Zadeh K; Jacobsen SJ
    Kidney Int; 2015 Sep; 88(3):622-32. PubMed ID: 25945406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T; Eon Y; Le Néel H; Seignard H; Battini J
    Arch Mal Coeur Vaiss; 2005; 98(7-8):761-6. PubMed ID: 16220744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on diagnosis and treatment of resistant hypertension.
    Pimenta E
    Iran J Kidney Dis; 2011 Jul; 5(4):215-27. PubMed ID: 21725176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistant hypertension: bad and getting worse.
    Ahmed MI; Calhoun DA
    Hypertension; 2011 Jun; 57(6):1045-6. PubMed ID: 21502566
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular risk factors are not treated to target in hypertensive patients in primary care.
    Nieburg I; Kahan T
    Blood Press; 2010 Jun; 19(3):176-81. PubMed ID: 20429693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observed factors responsible for resistant hypertension in a teaching hospital setting.
    Salako BL; Ayodele OE
    Afr J Med Med Sci; 2003 Jun; 32(2):151-4. PubMed ID: 15032461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systolic blood pressure: it's time to take control.
    Franklin SS
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):49S-54S. PubMed ID: 15607435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension.
    Castelpoggi CH; Pereira VS; Fiszman R; Cardoso CR; Muxfeldt ES; Salles GF
    Hypertens Res; 2009 Jul; 32(7):591-6. PubMed ID: 19444279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
    Weber MA; Julius S; Kjeldsen SE; Jia Y; Brunner HR; Zappe DH; Hua TA; McInnes GT; Schork A; Mancia G; Zanchetti A
    J Hypertens; 2012 Nov; 30(11):2213-22. PubMed ID: 23011525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Instrumental therapy of drug-resistant hypertension].
    Simonyi G; Bedros JR; Medvegy M
    Orv Hetil; 2013 Feb; 154(6):203-8. PubMed ID: 23376687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of resistant hypertension in renal transplant patients.
    Arias M; Fernández-Fresnedo G; Gago M; Rodrigo E; Gómez-Alamillo C; Toyos C; Allende N
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv36-8. PubMed ID: 23258809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the prevalence of resistant hypertension in the United States?
    Roberie DR; Elliott WJ
    Curr Opin Cardiol; 2012 Jul; 27(4):386-91. PubMed ID: 22596184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
    Ahola TL; Kantola IM; Mäki J; Reunanen A; Jula AM
    Eur J Prev Cardiol; 2012 Aug; 19(4):712-22. PubMed ID: 21609976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.
    Romano S; Idolazzi C; Fava C; Fondrieschi L; Celebrano M; Delva P; Branz L; Donato A; Dalbeni A; Minuz P
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):295-301. PubMed ID: 29959696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential hypertension.
    Messerli FH; Williams B; Ritz E
    Lancet; 2007 Aug; 370(9587):591-603. PubMed ID: 17707755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with resistant hypertension have more peripheral arterial disease than other uncontrolled hypertensives.
    Korhonen PE; Kautiainen H; Kantola I
    J Hum Hypertens; 2015 Jan; 29(1):46-9. PubMed ID: 25078489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.